[HTML][HTML] Growth hormone supplementation may not improve live birth rate in poor responders
J Zhu, Y Wang, L Chen, P Liu, R Li… - Frontiers in endocrinology, 2020 - frontiersin.org
Backgrounds: Growth hormone (GH) was used for many years to increase ovarian response
in poor ovarian responders (PORs). Although meta-analysis suggested that GH therapy …
in poor ovarian responders (PORs). Although meta-analysis suggested that GH therapy …
[PDF][PDF] Growth Hormone Supplementation May Not Improve Live Birth Rate in Poor Responders
J Zhu, Y Wang, L Chen, P Liu, R Li… - Front. Endocrinol. 11: 1 …, 2020 - scienceopen.com
Methods: A total of 3,080 expected PORs receiving and not receiving (control) GH adjuvant
therapy at Peking University Third Hospital from January 2017 to March 2018 were …
therapy at Peking University Third Hospital from January 2017 to March 2018 were …
Growth Hormone Supplementation May Not Improve Live Birth Rate in Poor Responders.
J Zhu, Y Wang, L Chen, P Liu, R Li… - Frontiers in …, 2020 - europepmc.org
Backgrounds: Growth hormone (GH) was used for many years to increase ovarian response
in poor ovarian responders (PORs). Although meta-analysis suggested that GH therapy …
in poor ovarian responders (PORs). Although meta-analysis suggested that GH therapy …
Growth Hormone Supplementation May Not Improve Live Birth Rate in Poor Responders
J Zhu, Y Wang, L Chen, P Liu… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Backgrounds: Growth hormone (GH) was used for many years to increase ovarian response
in poor ovarian responders (PORs). Although meta-analysis suggested that GH therapy …
in poor ovarian responders (PORs). Although meta-analysis suggested that GH therapy …
[HTML][HTML] Growth Hormone Supplementation May Not Improve Live Birth Rate in Poor Responders
J Zhu, Y Wang, L Chen, P Liu, R Li… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
Backgrounds: Growth hormone (GH) was used for many years to increase ovarian response
in poor ovarian responders (PORs). Although meta-analysis suggested that GH therapy …
in poor ovarian responders (PORs). Although meta-analysis suggested that GH therapy …